Reaction
Soft Tissue Sarcoma reporting signals
As of the last recalculation, Soft Tissue Sarcoma appears in 345 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is PAZOPANIB HYDROCHLORIDE (PRR 354.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pazopanib Hydrochloride | 109 | 354.8 | 356.2 |
| Ifosfamide | 15 | 44.0 | 44.0 |
| Thiotepa | 5 | 32.0 | 32.1 |
| Axicabtagene Ciloleucel | 4 | 24.7 | 24.7 |